Although early, CAR-T has shown some promising early results in solid tumors targeting mesothelin which is a molecule that is broadly expressed in many cancers such as various cancers such as lung, pancreas, breast, ovarian, and others [68]. This evidence concerns the gene MSLN and cancer.